Clinical trial

Tau PET Outcomes With Anti-amyloid Immunotherapies

NCT06723015

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2025-11-04

PhasePHASE2

Study timeline

Study start (actual)2025-11-04Date precision: day

Registry last updated2025-11-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cognitive Impairment, Mildunresolved

Dementia, Mildunresolved

Alzheimer Diseaseunresolved

Interventions

18F-AV-1451DRUG

Sponsors & collaborators

Mayo Cliniclead sponsor

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06723015 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.